The first batch of the “CoronaVac” Chinese vaccine arrived in Kazakhstan
Nur-Sultan, June 1
Today, following the results of negotiations with the People’s Republic of China, the first batch of CoronaVac vaccine arrived in Almaty by a special plane.
The drug is manufactured by the Sinovac Biotech Ltd Chinese biopharmaceutical company. The first batch of the Chinese vaccine “CoronaVac” consists of 500 thousand doses. This drug will be the fourth, which in the coming days will be available to citizens of Kazakhstan for vaccination against coronavirus infection COVID-19.
The implementation of the agreement on the supply of the CoronaVac vaccine from the PRC is seen as an example of the successful continuation of the initiated constructive cooperation with Chinese partners in jointly confronting the COVID-19 pandemic.
As noted in the Ministry of Health, the received batch of vaccine, along with the existing vaccines of Kazakhstan and Russian production, will be available at all vaccination points in the country.
The vaccine “CoronaVac” is approved by the Ministry of Health of the Republic of Kazakhstan for use in Kazakhstan and will supplement the list of vaccines “QazVac”, “Sputnik V” and “Hayat-Vax” already used in the country. Currently, CoronaVac is widely used in many countries around the world. Despite the ongoing large-scale campaign to vaccinate the population in the PRC, the Chinese side, noting the comprehensive and strategic partnership and good-neighborly relations, sent a vaccine of its own design to the Republic of Kazakhstan. The vaccine “CoronaVac” contains inactivated, active substance SARS-CoV-2 antigen. In one bottle 0.5 ml / dose, the drug assumes two vaccinations with an interval of 14-28 days. Categories of the population over 18 years old are subject to vaccinations. The vaccine is stored at a temperature of + 2 + 8 degrees.